摘要
目的探讨维生素AD制剂对婴幼儿哮喘的预防及治疗作用。方法将我院2016年6月—2018年4月收治符合婴幼儿哮喘诊断标准的110例患者,随机分为治疗组及对照组,两组均按《全球哮喘防治创议》(Golbal Initiative for Asthma)GINA方案给予辅舒酮雾化吸入治疗,治疗组加用维生素AD口服,发作期间治疗组及对照组均给予抗感染、止咳化痰、支气管扩张剂解痉治疗,随访6个月,观察统计两组的有效率和不良反应。结果治疗组有效率93.1%,对照组84.6%,差异有统计学意义(P<0.05)。结论维生素AD有助于治疗婴幼儿哮喘,不良反应少,患儿依从性好。
Objective To discuss the effect of vitamin AD preparation on prevention and treatment of infant asthma.Methods The 110 patients who met the diagnostic criteria of infant asthma from June 2016 to April 2018 were randomly divided into treatment group and control group.Both groups were treated with Golbal Initiative for Asthma(GINA)of Asthma Prevention and Control Program.The treatment group was treated with vitamin AD orally.The treatment group and the control group were treated with anti-infection,antitussive phlegm,bronchiectator antispasmodic therapy.The effective rate and adverse reactions were observed and counted for 6 months.Results The effective rate of treatment group was 93.1%,control group 84.6%,the difference was statistically significant(P<0.05).Conclusion Vitamin AD is useful to treat childhood asthma,and Less adverse reactions.
作者
岳欣峰
王兰英
付爱学
YUE Xinfeng;WANG Lanying;FU Aixue(Neonate Department,Rongcheng Maternal and Child Health Hospital,Rongcheng Shandong 264300,China;Department of Respiratory Medicine,Rongcheng Shidao People's Hospital,Rongcheng Shandong 264300,China)
出处
《中国卫生标准管理》
2020年第24期103-105,共3页
China Health Standard Management
